Innovative solutions to study epigenetic modifications in disease
Epigenetics is a major determining factor in cellular differentiation, growth, disease progression and therapeutic response. Along with environmental factors such as diet and stress, changes in the epigenome regulate gene expression and may have profound impacts on cancer and other complex diseases. However, very little is known about which genes are turned on or off, the role of epigenetics in heritability, or how these changes can lead to disease onset.
Swift offers innovative next-generation sequencing (NGS) library prep solutions for methylation sequencing (Methyl-Seq) and Chromatin IP sequencing (ChIP-Seq) to help you extract more genomic information from limited specimens. Whether working with single cells or picogram-level inputs from small amounts of complex tissue, our sensitivity and robust technologies help you unlock challenging samples to make bigger, faster scientific breakthroughs.